United Kingdom · Life Sciences Lvl3
Athernal Bio Ltd
Athernal Bio Ltd is a UK early-stage company with 1 public funding or programme announcement on record, most recently 1 Jul 2026.
Announcements
Innovate UK funding awarded
£697,565 · Investment Accelerator grant; “Translational de-risking and validation of an RNA immunotherapy for high-risk clonal haema”; East of England
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.